These comprehensive surveys of research reports and case study literature about IM injections revealed that administering medication intramuscularly can produce a variety of serious adverse effects, including skin and tissue trauma, muscle fibrosis and contracture, nerve palsies and paralysis, and infectious processes such as abscesses or gangrene. But two recent surveys, both authored by nurses, provide a more scientific rationale for IM site selection ( AACN 5: 207-214, May 1994 Applied Nurs.Res. Choosing which site to use has been, for the most part, a matter of personal preference (the nurse's or the patient's), tradition, or convenience. Where should an intramuscular (IM) injection be given? Nurses learn there are four possible sites: the arm (deltoid) thigh (vastus lateralis) upper outer posterior buttock (gluteus maximus), also referred to as the dorsogluteal site and the lateral hip (gluteus medius), also called the ventrogluteal site. Facing Ethical Challenges with Strength and Compassion.Establishing Yourself as a Professional and Developing Leadership Skills.Ensuring Patient & Family Centered Care.Developing Critical Thinking Skills and Fostering Clinical Judgement.Alteplase Injection for Acute Ischemic Events.
Lippincott Clinical Conferences On Demand.Continuing Education Bundle for Nurse Educators.Lippincott NursingCenter’s Critical Care Insider.Lippincott NursingCenter’s Career Advisor.COVID-19 2022 Update: The Nursing Workforce.An Unforeseen Path from Critical Care Nurse to Editor-in-Chief of American Journal of Nursing.When Nurses Speak, People Listen: An Interview with Pat Patton.Academic/Practice Innovation: An Interview with Dr.Clinical Judgment: The Doing that Happens after Critical Thinking.Debriefing: It Should Always Be About the Learner.Nurse Wellness Is Not Just About Resiliency.Creating Learning Environments to Advance Health Equity.
0 kommentar(er)
